Evidence map›Paper›PMID 40580294›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Targeted Amplicon Genotyping by Sanger Sequencing.

Anthony Torres, Reginald Gaudino

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anthony TorresCannabis Research Institute, Discovery Partners Institute, University of Illinois System, Chicago, IL, USA.ORCID https://orcid.org/0000-0003-3631-3079
Reginald GaudinoFront Range Biosciences, Lafayette, CO, USA.ORCID https://orcid.org/0000-0001-5902-5606

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This chapter presents a protocol for Sanger sequencing, a conventional yet rapid, cost-effective, and highly accurate method for targeted sequencing. It involves designing specific primers for forward and reverse template extension reactions, during which fluorophore labeled, chain terminating dideoxynucleotides are incorporated into newly replicated DNA molecules. The resulting end-labeled terminated products are separated by electrophoresis, enabling precise base identification within the amplicon. Chromatogram analysis further allows for the detection of nucleotide changes that may correspond to amino acid variations in targeted genes from different samples.

Indexed as

Genotyping TechniquesSequence Analysis, DNADNADNA PrimersGenotypeHigh-Throughput Nucleotide SequencingHumansPolymerase Chain ReactionDNADNA PrimersAmpliconChromatogram analysisDNAElectrophoresisEnd termination reactionSanger sequencingSingle nucleotide polymorphism (SNP)SNP detectionTargeted sequencing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.